We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Global X-Ray Detectors Market to Surpass USD 4.5 Billion Due to Increasing Use of CT Scans for COVID-19 Diagnosis

By LabMedica International staff writers
Posted on 19 Oct 2021
Print article
Illustration
Illustration

The global X-ray detectors market is projected to expand at a CAGR of 5.9% during the forecast period of 2021-2031 to reach USD 4.6 billion by 2031, driven mainly by the rising use of radiographic chest scans for COVID-19 diagnosis.

These are the latest findings of Transparency Market Research (Albany, NY, USA), a next-generation market intelligence provider. The market growth will be further aided by the increasing use of X-ray detectors in several applications, growing incidences of gastrointestinal, cardiovascular, oral, and genitourinary disorders and introduction of innovative X-ray detectors for security, industrial, medical, dental, veterinary, and other purposes. In addition, technological advancements that will enable detectors to provide better detail, higher resolution, and decreased exposure will also provide a boost to the global X-ray detectors market.

The use of X-ray detectors for COVID-19 diagnosis will prove to be a key contributor to market growth. Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests are accurate in detecting COVID-19 in individuals, but are very complicated, time-consuming, and costly. Stakeholders in the X-ray detectors market are taking advantage of this opportunity to increase the availability of radiological examination through X-ray such as CT (Computed Tomography) scans, which is a cost-efficient and easily available option. The rising use of X-ray detectors for radiographic chest scans during the COVID-19 pandemic offers substantial growth opportunities.

These detectors are also being optimized by the players for various industrial inspection and material sorting applications. In addition, wider application of X-ray detectors in image-guided radiation therapy, fluoroscopy, digital radiography, cone beam CT, digital tomosynthesis, and others are expected to further fuel market growth. The growing focus of several countries on developing a well-established healthcare infrastructure is also likely to drive the growth of the global X-ray detectors market.

Flat panel detectors are expected to observe a rise in demand, as they offer various advantages such as uniform imaging quality, less image distortion, low time consumption, good reproducibility, and better patient condition access, among others. In addition, they are proven to be very successful in high exposure interventional procedures. Among panel types, the large panel category of the X-ray detectors market is expected to witness promising growth. The growing number of patients undergoing diagnostic imaging tests, and expanding adoption of new and advanced large panel detectors are likely to propel the growth of the X-ray detectors market.

Geographically, North America held the largest share of the global X-ray detectors market in 2020 and is expected to maintain its position during the forecast period. The growing number of dental CBCT scans in the US due to increasing dental diseases among a considerable share of its population is anticipated to propel the growth of the North American X-ray detectors market. Furthermore, the Asia Pacific X-ray detectors market is also projected to grow rapidly during the forecast period. Increasing efforts by several countries in the region to develop a well-established healthcare infrastructure, coupled with novel product launches in China and Japan, are expected to fuel the growth of the X-ray detectors market in the Asia Pacific.

Related Links:
Transparency Market Research 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
All-in-one Molecular Diagnosis System
Panall 8000

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.